C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/64 (2006.01) A61K 31/465 (2006.01) A61P 3/00 (2006.01) A61P 25/34 (2006.01) C07D 213/74 (2006.01)
Patent
CA 2602787
The present invention relates to compounds of the formula (I) wherein X and R1 to R8 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors, such as obesity.
L'invention concerne des composés de formule (I) dans laquelle X et R1 à R8 sont tels que définis dans la description et les revendications et des sels de ceux-ci acceptables sur le plan pharmaceutique. Les composés sont utiles dans le traitement et/ou la prophylaxie de maladies associées à la modulation des récepteurs CB1, telle que l'obésité.
Hebeisen Paul
Iding Hans
Nettekoven Matthias Heinrich
Obst Ulrike
Roever Stephan
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Pyridine-3-carboxamide derivatives as cb1 inverse agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine-3-carboxamide derivatives as cb1 inverse agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine-3-carboxamide derivatives as cb1 inverse agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1497347